Ren Qian, Liu Yao, Wang Jiaqi, Ren Shuang, Guan Xiaobing
Department of Oral Medicine, Beijing Stomatological Hospital, Capital Medical University, Beijing, CHN.
Cureus. 2025 Jul 27;17(7):e88865. doi: 10.7759/cureus.88865. eCollection 2025 Jul.
Pyostomatitis vegetans (PSV) is a rare inflammatory condition that has been strongly associated with inflammatory bowel disease (IBD). Additionally, certain cases of PSV have been reported to co-occur with pyodermatitis vegetans (PDV), resulting in a distinct mucocutaneous manifestation. Herein, we present a clinical case of PSV in a 64-year-old male patient diagnosed with ulcerative colitis (UC). The oral lesions demonstrated complete resolution following treatment with systemic glucocorticoids and immunosuppressants, in conjunction with targeted therapy for the underlying intestinal disease. During longitudinal follow-up, the patient subsequently developed PDV and, unexpectedly, exhibited recurrent bullous eruptions on cutaneous surfaces, specifically localized to the axillary and dorsal regions six years post-initial diagnosis. Enzyme-linked immunosorbent assay (ELISA) analysis revealed significantly elevated titers of circulating anti-BP230 antibodies in the serum samples. These clinical and immunologic findings, together with histopathological evaluation of the cutaneous lesions, established an additional diagnosis of bullous pemphigoid (BP). Both BP and PSV-PDV conditions remained clinically stable under treatment with topical and systemic glucocorticoids, with circulating anti-BP230 antibody titers normalizing eight months after the initiation of therapy. To the best of our knowledge, this represents the first documented case of a patient with PSV-PDV developing BP mediated by anti-BP230 antibodies during long-term follow-up observation. This finding underscores a potential novel disease association that warrants further exploration.
增殖性口炎(PSV)是一种罕见的炎症性疾病,与炎症性肠病(IBD)密切相关。此外,据报道,某些PSV病例与增殖性脓皮病(PDV)同时出现,导致一种独特的黏膜皮肤表现。在此,我们报告一例64岁男性PSV临床病例,该患者被诊断为溃疡性结肠炎(UC)。经全身糖皮质激素和免疫抑制剂治疗,并结合针对潜在肠道疾病的靶向治疗后,口腔病变完全消退。在长期随访期间,患者随后出现了PDV,出乎意料的是,在初次诊断六年后,皮肤表面出现了复发性大疱性皮疹,特别是局限于腋窝和背部区域。酶联免疫吸附测定(ELISA)分析显示血清样本中循环抗BP230抗体滴度显著升高。这些临床和免疫学发现,连同皮肤病变的组织病理学评估,确立了大疱性类天疱疮(BP)的额外诊断。在局部和全身糖皮质激素治疗下,BP和PSV-PDV病情均保持临床稳定,治疗开始八个月后循环抗BP230抗体滴度恢复正常。据我们所知,这是首例记录在案的PSV-PDV患者在长期随访观察期间发生由抗BP230抗体介导的BP的病例。这一发现强调了一种潜在的新的疾病关联,值得进一步探索。